This study looked at 255 patients who had recently suffered a heart attack. Researchers focused on how well these patients followed their prescribed high-intensity statin treatment, specifically rosuvastatin or atorvastatin, and how that affected their heart health over 52 weeks.
Patients who were consistent with their medication showed much better results. These included lower LDL-C levels and a significant reduction in the amount of plaque in their arteries. They also showed a greater increase in the thickness of the fibrous cap, which is a protective layer over arterial plaque. These improvements were much more pronounced in the group that stayed on their medication compared to those who did not.
While the study confirms that staying on your prescribed statin is important for heart health, it is a small sub-study of a larger trial. Only a small number of patients reported issues with tolerating the medication. You should talk to your doctor to discuss the best way to manage your specific heart health plan.
Common questions
How does staying on a statin help after a heart attack?
Patients who followed their high-intensity statin regimen showed greater reductions in LDL-C levels and a significant decrease in atheroma volume. They also showed a higher increase in fibrous cap thickness. These results suggest that consistent medication helps improve specific markers of heart health after a heart attack.
What specific heart markers improved for patients who took their medication?
Patients who were consistent with their statins showed a reduction in LDL-C levels of 2.73 mmol/L compared to 0.07 mmol/L for those who were not. They also showed a 60.6 reduction in the maximum lipid core burden index and a 48.53 micrometer increase in fibrous cap thickness.
Is the statin medication well-tolerated by patients?
The study reported that only 4 patients, or about 1.3 percent of the group, reported statin intolerance within the 52-week period. This suggests the medication was generally well-tolerated by the majority of the patients in the study.
